drugset / Trial / NCT04702906
Trimetazidine As a Potential Adjuvant Therapy in Acute Aluminum Phosphide Poisoning-induced Cardiotoxicity
RandomizedParallel-groupDouble-blindTreatment
Summary
The aim of the present study is to evaluate the potential adjuvant therapeutic effect of trimetazidine in treatment of acute AlP poisoning-induced cardiotoxicity.
Timeline
- Start
- 2021-02
- Primary completion
- 2021-06
- Completion
- 2021-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Trimetazidine | Small molecule | 20 mg | Oral |